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ABSTRACT
Objective To investigate whether the use of apatient 
decision aid (PDA) for insulin initiation fulfils its purpose 
of facilitating patient-centred decision-making through 
identifying how doctors and patients interact when using 
the PDA during primary care consultations.
Design Conversation analysis of seven single cases of 
audio-recorded/video-recorded consultations between 
doctors and patients with type 2 diabetes, using a PDA on 
starting insulin.
Setting Primary care in three healthcare settings: (1) one 
private clinic; (2) two public community clinics and (3) one 
primary care clinic in a public university hospital, in Negeri 
Sembilan and the Klang Valley in Malaysia.
Participants Clinicians and seven patients with type 
2 diabetes to whom insulin had been recommended. 
Purposive sampling was used to select a sample high 
in variance across healthcare settings, participant 
demographics and perspectives on insulin.
Primary outcome measures Interaction between doctors 
and patients in a clinical consultation involving the use of a 
PDA about starting insulin.
Results Doctors brought the PDA into the conversation 
mainly by asking information-focused 'yes/no' questions, 
and used the PDA for information exchange only if patients 
said they had not read it. While their contributions were 
limited by doctors’ questions, some patients disclosed 
issues or concerns. Although doctors’ PDA-related 
questions acted as a presequence to deliberation on 
starting insulin, their interactional practices raised 
questions on whether patients were informed and their 
preferences prioritised.
Conclusions Interactional practices can hinder 
effective PDA implementation, with habits from ordinary 
conversation potentially influencing doctors’ practices 
and complicating their implementation of patient-centred 
decision-making. Effective interaction should therefore 
be emphasised in the design and delivery of PDAs and in 
training clinicians to use them.
INTRODUCTION
Shared decision-making (SDM), which involves 
doctors and patients exchanging information, 
deliberating on treatment options and reaching 
a mutually accepted decision,1 is widely consid-
ered the ideal treatment decision-making 
model.2–4 In contrast with paternalistic or 
informed decision-making, SDM emphasises 
partnership between doctor and patient,5 
which is particularly significant in managing 
chronic illnesses such as diabetes, as patient 
self-management plays a crucial role. One 
means of implementing SDM is using patient 
decision aids (PDAs).6 These are designed 
to support treatment decision-making by 
providing patients with evidence-based infor-
mation on their illness and treatment options 
in print, DVD or digital form.6 They can also 
help ‘create a conversation’,7 in which patients 
can seek clarification on information and 
discuss concerns, values and preferences.
Research on PDA use has identified 
doctors’ practices and these include giving 
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Strengths and limitations of this study
 ► By providing a talk-based view of how doctors 
and patients use a patient decision aid  (PDA), this 
study adds information in an area which is under-
represented in research on PDAs.
 ► The data involve a range of patient perspectives 
which emerge in the context of starting insulin for 
type 2 diabetes in Malaysia’s multicultural setting 
(the use of traditional medicine, language issues, 
fear of injections, resistance to insulin), showing how 
doctors and patients manage these perspectives in 
talk.
 ► As the sample size is small, it may not be possible 
to draw general conclusions on patterns of PDA use.
 ► However, the analysis can provide insights into how 
doctors’ interactional practices in initiating talk on 
PDAs could be adapted to better fulfil their aims of 
supporting informed and shared decision-making.
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fewer details about treatment to older or less-educated 
patients,8 dominating discussions9 and not using PDAs 
as prescribed, by neglecting to use them, providing inac-
curate information or using PDAs to support personal 
biases.10 11 Although Tiedge et al conclude that the flexible 
use of PDAs encourages discussion,12 only a few studies 
describe how doctors and patients use PDAs in consul-
tations11 12 and these tend to overlook the collaborative 
nature of interaction, for example, by using quantitative 
methods,8–11 or focusing only on doctors.11
Qualitative methods of interaction analysis, such as 
conversation analysis (CA), have been used to examine 
how doctors and patients jointly perform social actions 
through talk in various clinical contexts.13–17 By analysing 
talk as it unfolds in consultations, CA research has iden-
tified patterns of doctor–patient interaction,13 15 helped 
operationalise patient participation and shared deci-
sion-making18–21 and produced findings applicable in 
medical practice and training.22 23
In this study, we draw on the tools of CA to explore 
the way doctors and patients with type 2 diabetes use a 
printed PDA for decisions about insulin. By examining 
doctor–patient talk in different patient contexts, we hope 
to extend the discussion on PDA use beyond doctors’ 
practices to include the crucial but often overlooked role 
of the patient. Our objective is to investigate whether the 
use of the PDA for insulin initiation fulfils its purpose 
of facilitating patient-centred decision-making through 
identifying how doctors and patients interact when using 
the PDA during primary care consultations.
METHOD
Setting
The data were collected during a project to develop and 
test a PDA about starting insulin for patients with type 
2 diabetes. Guided by the Ottawa Decision Support 
Framework,24 the 13-page PDA covers patients’ concerns; 
comparison of treatment options; assessment of patient 
knowledge and values clarification, and finally, prompts 
a decision if patients are ready. Patients can engage with 
the content, checking options or making notes about 
topics for discussion with their doctors (see http:// dmit. 
um. edu. my/ ? modul= DMIT_ PDA).
To test how the PDA could be implemented, a group 
of healthcare providers (HCPs), including 12 doctors, 
2 nurses and 1 pharmacist, used it in consultations. 
HCPs received a guidebook (Healthcare Professionals’ 
Guide to the Patient Decision Aid, http:// dmit. um. edu. 
my/ images/ dmit/ doc/ PDA_ HCP% 20Guide. pdf) and 
2 hours of training on implementing the PDA, which 
can be used preconsultation, by the patients alone or 
with their families, or in consultation with the HCP. The 
training was conducted by SDM experts with clinical 
experience (authors NCJ, LPY and KLA), and included 
lectures, interactive activities and role play. HCPs were 
trained in different manners of delivery of the PDA; 
however, the specifics of delivery were not prescribed to 
allow HCPs to tailor their PDA use to their setting and 
patients. Subsequently, consultations were held in three 
healthcare settings: private clinics, public community 
clinics and the primary care clinic of a public univer-
sity teaching hospital in Negeri Sembilan and the Klang 
Valley in Malaysia between November 2012 and April 
2013. All patients received the PDA in advance, at times 
ranging from the last visit to the HCP, or several months 
in advance to just hours before the consultation, when 
they were already in the waiting room.
Data collection
To capture a range of doctor and patient practices in 
using the PDA, purposive sampling was used, aiming for 
variance in healthcare settings, patient perspectives on 
insulin and sociodemographics. For doctors, the demo-
graphic variables were clinical qualifications (general 
practitioner, medical officer or specialist) and gender. 
Patients were selected according to age, gender, ethnicity 
and educational background. For linguistic reasons, 
participants were selected from the major ethnic groups 
in Malaysia, namely Malay, Chinese and Indian. Since 
some patients are not sufficiently fluent in the consul-
tation language, which could be Malay or English, or as 
is common in Malaysia, some mixture of Malay, English, 
Tamil or Chinese, versions of the PDA are available in all 
four languages.
Fifteen consultations were audio recorded, with 
supplementary video recordings for four hospital-based 
consultations. As a preliminary exploration of PDA use 
in interaction, this paper reports on single-case analyses 
of doctor–patient consultations in English. Consultations 
with other HCPs were excluded in view of their different 
roles in decision-making, in that nurses and pharmacists 
may use the PDA to counsel the patient, but the treatment 
decision itself is made with the doctor. In line with the 
CA practice of analysing data in a common language (eg, 
18–23), this paper focuses on consultations conducted 
mainly in English to facilitate comparison of language 
structures across the data. The final dataset for this paper 
comprises seven consultations by five clinicians: one 
general practitioner (private clinic) and four medical 
officers (public clinics and hospital) (see online supple-
mentary appendix A).
Analysis
In accordance with CA methods, the recorded consul-
tations were anonymised, and then transcribed using 
Jefferson’s transcription conventions25 (see online supple-
mentary appendix B) by author AS, and reviewed by 
authors ZMD and AZ. Sequences of talk in which the PDA 
was mentioned or used were identified through repeated 
listening and viewing by AS, a doctoral student in applied 
linguistics, and reviewed by ZMD, a professor in applied 
linguistics. To facilitate analysis, CA research often 
focuses on one phase of the consultation, such as open-
ings or examination.16 Since PDA talk occurs at different 
points and with varying frequency in the consultations, 
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we focused on initial PDA talk to enable analysis across 
consultations. Because opening sequences influence how 
consultations unfold,15 16 26 the initial sequences of PDA 
talk were considered an appropriate starting point at 
which to begin exploring PDA use in the data.
Given the limited research on interaction surrounding 
PDAs, we made preliminary investigations of several 
single episodes,27 28 describing the interactional aspects 
of the talk (eg, turn taking, structural organisation, turn 
design and lexical choice29) in relation to patient-centred 
decision-making. As the analysis proceeded, the work was 
reviewed by the research team, the initial interactional 
analysis being made by the applied linguists (AS, ZMD 
and AZ) followed by input from the clinicians (NCJ, 
KEM, LPY and KLA) and healthcare sociologist (LYK).
This study received ethics approval from the Medical 
Research and Ethics Committee, Ministry of Health, 
Malaysia (Ref No: NMRR-10-1233-7299) and the Medical 
Ethics Committee, University of Malaya Medical Centre, 
Kuala Lumpur (MECRef No: 841.6). All participants gave 
informed consent.
RESULTS
Doctors began by asking whether patients had read and 
understood the PDA, which is unsurprising given their 
legal and ethical duty to ensure patients make informed 
decisions. The PDA was then used to exchange informa-
tion or to initiate deliberation on treatment depending 
on whether the patients had read it or not.
Exchanging information
In two consultations (B8 and B15) in community clinics, 
the patient disclosed that she had not read the PDA. 
The doctor did not bring up the PDA immediately, but 
began by addressing test results (B8) or asking about the 
patient’s lifestyle (B15). Both patients initially affirmed 
they had read the PDA, and only revealed that they had 
not on further questioning. The doctors then began 
going through the PDA with the patients, using it to 
provide information or to elicit patient perspectives 
towards starting insulin. Here, we present an extract from 
consultation B8 to exemplify the interactional practices 
observed in this context.
The doctor (DR1) has given the patient (P1) her recent 
test results, showing a high sugar level. P1 has disclosed 
that she had stopped taking her oral medication, and is 
only taking Ayurvedic (traditional Indian) medicine. After 
explaining the complications of sustained high sugar, 
DR1 brings up the PDA 6 min into the consultation, with a 
polar question (requiring a yes/no response) on whether 
P1 has read it (table 1: extract 1, 283).
P1’s affirmation of this ("Yap") is hurried, overlapping 
DR1’s turn. Acknowledging P1’s response (286), DR1 
shifts the topic away from the PDA to ask two polar ques-
tions, to confirm P1’s preference for Ayurvedic medicine 
(286–287) and to explore the reasons behind her prefer-
ence (291–292 "you feel that Ayurvedic can help you?"). P1 
responds with affirmations but does not elaborate (288, 
293). DR1’s next question (294–295) appears to seek P1’s 
view on the effectiveness of Ayurvedic medicine. However, 
by foregrounding P1’s high sugar against Ayurvedic medi-
cine, DR1’s question presents a rhetorical contradiction 
which limits P1’s ability to respond affirmatively. P1 then 
challenges DR1 to defer her evaluation until the next 
appointment (296–297), which receives DR1’s overlapped 
acceptance (298). P1’s laughter (297, 299) indicates her 
orientation towards a delicate situation.30 31
The ‘but’ that prefaces DR1’s response after her initial 
acceptance (table 2: extract 1a, 300) suggests she intends 
to continue the topic. She asks again whether P1 has read 
the PDA. After a hesitant affirmation, P1 discloses that 
she has not read the PDA. In response, DR1 echoes P1’s 
‘not yet’ followed by ‘Okay’ uttered four times, indicating 
she now understands the situation (304). DR1 begins 
explaining the content of the PDA, going through the 
first section, "What are your concerns?" with P1. It is here 
that the doctor shifts from merely topicalising the PDA to 
going through it. Reading from a list of common patient 
concerns, DR1 rephrases the affirmative sentences in 
the PDA as questions (310, 314 and 316), attempting 
Table 1 Extract 1—consultation B8 (public clinic)
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to elicit P1’s concerns. For example, DR1 reformulates 
the sentence "I am afraid of injections and pain" as "Are 
you afraid of injections and pain?" (310). After P1 gives 
several negative responses, DR1 seeks confirmation that 
P1’s decision against insulin is due to her preference 
for Ayurvedic medicine, rather than unstated concerns. 
This sequence is repeated several times throughout the 
consultation (not shown), with DR1 going through the 
sections of the PDA and P1 reiterating her preference for 
Ayurvedic medicine.
Opening up deliberation on treatment
Having confirmed that a patient has read the PDA, the 
doctor can ascertain further the patient’s preparedness 
for decision-making. Initial considerations are largely 
information-focused: whether the patient understands 
the content or has any questions. Also relevant are patient 
concerns, values and opinions. We present extracts from 
four consultations involving patients who claim to have 
read the PDA. The extracts show four patient responses 
to doctors’ initiation of deliberation on treatment: 1) not 
raising issues/concerns; 2) raising issues about the PDA; 
3) disclosing fears; and 4) disclosing a preference against 
insulin.
Patient does not raise issues or concerns
Two patients (consultations A4 and C14) do not raise 
issues or express concerns in response to the doctors’ 
PDA-related questions. After asking about the patients’ 
comprehension and opinion of the PDA, the doctors 
elicit a decision from the patients. Extract 2 (tables 3-4) 
is from consultation A4, a triadic consultation involving 
Table 2 Extract 1a—continued
  
Table 3 Extract 2—consultation A4 (private clinic)
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the patient’s husband (H), who helps interpret between 
English and Tamil. The doctor (DR2) initiates the PDA 
talk early in the consultation, by asking whether the 
patient has read it.
DR2’s initial reference to the PDA is formulated as a 
question (004), and comes immediately after a brief iden-
tity-confirmation sequence, which functions as a greeting. 
Ending with a tag question, the enquiry ("You have read the 
book, right?") favours an affirmative response, which both 
P2 and H provide (005, 006). DR2 then asks for P2’s views 
on the PDA using a Wh-question (open-ended question). 
After a silence, P2’s response displays uncertainty ("I think, 
I’m not sure"). Her laughter, which is reciprocated by DR2, 
indicates a delicate situation.30 31 H resumes discussing 
the PDA (011), delivering a favourable assessment of it 
("…very simple language"). P2 then partially echoes her 
husband, briefly interrupted by DR2’s encouragement to 
complete her utterance ("Yes?" 015). Overlapped by H’s 
elaboration, P2 completes her brief assessment of the 
PDA.
Following further elaboration by P2 and H (omitted), 
DR2 resumes questioning (table 4: extract 2a—
continued), with a Wh-question (037). Although 
designed to allow P2 to express her opinion, the question 
remains focused on the PDA ("the book"), rather than 
the decision on starting insulin. Producing a preferred 
response, P2 describes the PDA as "easy" (038). DR2 
then asks whether P2 understands the PDA. P2’s pauses, 
hesitation and incomprehensible utterance indicate her 
difficulty comprehending the doctor’s question, leading 
to her delayed response (042–043). She speaks in Tamil 
to H, who then confirms that P2 has, in fact, under-
stood (045–046). DR2 seeks this confirmation from P2 
("You understand, ya?" 048), receiving a weak affirmation 
(049). Taking the unmarked token as confirmation of 
understanding, the doctor commences talk on the treat-
ment decision with a series of questions, soliciting P2’s 
agreement to start insulin (050), and her explanation 
for (055) and confirmation of (063–065) this decision. 
DR2’s question presents the decision as a proposal, with 
P2 providing the relevant and preferred acceptance 
through minimal responses (Mh-054, Ya-066). This shows 
DR2 orienting, however minimally, to P2’s right to accept 
or reject the recommended treatment. Yet, in exploring 
P2’s decision, DR2’s use of ‘have to’ depicts starting 
insulin as an obligation ("you know why you have to take the 
insulin?" 055–056), which is mirrored in P2’s response 
that she has "no choice" and "must take the insulin".
Table 4 Extract 2a—continued
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Patient raises issues about the PDA
Consultation A3 is also conducted by D2, who begins 
as she does in consultation A4, by enquiring whether 
the patient has read "the book" (table 5: extract 3). The 
rising intonation of DR2’s confirmation-seeking state-
ment indicates a response is required, and the wording 
shows affirmation is expected (lines 001–002). P3 
responds with a minimal affirmation, which the doctor 
echoes ("Yes" 004). She then asks a Wh-question to elicit 
P3’s opinion, repeating it (006) after P3’s overlapping 
turn (005). After a silence (007), P3 produces an assess-
ment of the PDA (008–012), describing its contents as 
"just basic". DR2 then asks about the information P3 
requires.
P3 begins listing questions he would like the PDA to 
address, beginning with the effects of sustained high glucose 
level (017–018). DR2’s response, a minimal acknowledge-
ment token ("Right" 020), leads P3 to continue, with a 
question about ‘overcontrol’ (021), which refers to hypo-
glycaemia, a side effect of insulin.
Patient discloses fear of injections
Consultation C12 is conducted in a public hospital by 
DR3, who had given the patient (P4) the PDA on her 
previous visit. The doctor brings the PDA up early, after a 
brief greeting (not shown in table 6: extract 4). As video 
recording was possible, participants’ physical actions were 
also transcribed.
Unlike the other doctors, DR3 initiates the topic of the 
PDA with statements (17–26), referring to the previous 
consultation when the PDA was given. DR3 describes the 
PDA as "something on starting insulin" rather than something 
to help the patient decide whether or not to start insulin, 
and asks if P4 has read it (028). P4’s affirmative response is 
acknowledged by DR3, who asks another yes/no question 
on P4’s experience of reading the PDA (033). P4’s contri-
butions throughout these sequences are minimal, namely 
continuers "mm" (020) and "hm" (031), nodding (023) or 
brief confirmation (029). Her pause after DR3’s question in 
line 033, followed by nodding, smiling and the drawn-out 
final syllable of her one-word echo response (036-Easy), 
indicate some hesitation. Using ‘but’ to signal a topic shift, 
P4 then voices her fear of needles. Laughter from both sides 
indicates that they recognise the situation as being delicate. 
However, while acknowledging P4’s fears with a confir-
mation-type question (040), DR3 does not immediately 
address them. Instead, he asks whether P4 understands the 
content in the PDA (042–049), with P4 giving minimal affir-
mations. DR3 starts addressing P4’s fears only after several 
question-answer sequences (not shown).
Patient discloses the decision not to start insulin
Throughout consultation C11, the doctor (DR4) refers 
several times to the PDA. Extract 5 (table 7) is from the 
beginning of the consultation. The transcript records the 
participants’ physical actions.
DR4 initiates PDA talk (001) by enquiring whether P5 
has any problems with "the book", or whether she under-
stands it, beginning what appears to be an invitation to 
talk or ask questions ("or you want to"). P5 interrupts 
this (003), denying she has any difficulty understanding 
it ("yes, no, no"), and then affirms this with the state-
ment "I understand". She intercepts DR4’s next turn, 
and instead of discussing the PDA, pursues her own 
agenda. Using ‘but’ to introduce a contrasting topic 
(005), she proposes her decision to wait with a strong 
modal (‘have to’) and refuses insulin without explicitly 
mentioning it. DR4 acknowledges this with "Okay", but 
continues asking P5 if she understands the PDA (006). 
P5 briefly affirms this, handing DR4 her PDA (008). She 
Table 5 Extract 3—consultation A3 (private clinic)
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responds only with a nod (012, 014) to DR4’s further 
talk on the PDA. P5’s lack of uptake forces the doctor 
to focus on her preference, for which DR4 solicits 
confirmation (015). P5 nods again, adding a minimally 
verbalised confirmation that she does not want insulin 
(016).
DISCUSSION
Our analysis of the initial sequences of doctor–patient 
talk shows that the use of the PDA did not effectively 
support patient-centred decision-making. The main 
barriers to fulfilling the PDA’s informational purpose 
are that patients’ disclosures about having read it may 
not be reliable, and that it is unclear whether patients 
understood the PDA content since its use was limited 
in most consultations. Also, while PDA talk led towards 
deliberation on treatment, the doctors’ interaction was 
not patient-centred, even when patients mentioned their 
concerns or showed that they found these conversations 
difficult. Moreover, if the patients did not bring up issues, 
Table 6 Extract 4—consultation C12 (primary care clinic)
  
Table 7 Extract 5—consultation C11 (primary care clinic)
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treatment was not deliberated at length, and doctors 
presented the decision as acceptance or refusal of insulin, 
rather than a choice among several options.
While the initial sequences of PDA talk are not consul-
tation ‘openings’ in the traditional sense, they mark the 
beginning of decision-making, in that patient responses 
to doctors’ PDA-related questions lead to different 
trajectories of PDA use: information exchange, or delibera-
tion, culminating in a decision on whether or not to start 
insulin. Although the trajectories correspond with the 
analytical stages of SDM,1 the interaction in the initial 
sequences of talk show that patients’ knowledge, concerns 
and preference are not sufficiently explored, which has 
implications for the decision-making process that follows.
As figure 1 shows, the doctors’ initial questions are 
information-focused, mostly yes/no questions. Yet some 
patients respond by disclosing issues or even refusing 
insulin. If patients do not resist, doctors move the consul-
tation towards closure, seeking patient acceptance of the 
recommended treatment. Treatment is only deliberated 
on if patients resist insulin and the PDA is used as a tool 
for information exchange only if patients say they have 
not read it. While this uses time efficiently, it does raise 
questions about whether patients are actually informed 
and their contributions are given due priority.
Our findings show further how doctors’ questioning 
practices constrain patient contributions.19 22 32 33 By 
asking mainly yes/no questions about whether patients 
have read or understood the PDA, the doctors rely on 
single-word responses to decide if further information 
exchange is needed. As extract 1 (tables 1-2) shows, a 
patient's first response to "Have you read the PDA?" may 
be unreliable. Other comprehension-focused questions 
also tend to generate ‘no issue’ responses, for example, 
patients say ‘yes’ to enquiries such as "Do you under-
stand?"/"You know why you have to take the insulin, 
right"; and ‘no’, to "Do you have any questions?". Because 
the doctors move quickly from PDA-related questions to 
deliberation on insulin, superficial assessment of patient 
knowledge means they risk making a decision with unin-
formed patients.
Heritage’s32 proposition that norms from ordinary 
conversation cause dysfunction in doctor–patient 
interaction may provide an explanation, since the doctors’ 
tendency not to thoroughly explore patient knowledge 
may be influenced by norms of news delivery. Given the 
deeply ingrained tendency to avoid telling others infor-
mation they already know,32 doctors may habitually avoid 
probing if a patient claims to have understood the PDA, 
especially when several doctors manage one patient, as 
they may not know what was discussed in previous consul-
tations.
Preference organisation, or the bias that phrasing 
conveys towards specific responses,32–35 may both explain 
and offer solutions for patients' hesitation to disclose that 
they have not read the PDA. Yes/no questions generally 
prefer 'yes-type' responses, unless negative polarity, for 
example, 'any', is introduced; moreover, doctors’ ques-
tions tend to favour 'no problem' responses.32 33 For 
example, patients tend to disclose unmet concerns when 
doctors use 'some/other', rather than ‘any', in closing 
questions (eg, "Do you have other problems you want to 
discuss?").33 35 Additionally, the preference for an affilia-
tive response36 may prevent patients from admitting that 
they have not read the PDA as recommended. Patient 
disclosures may be encouraged through repeated ques-
tioning (eg, extract 1), but doctors could also err on the 
side of caution by using questions that prefer negative 
responses, (eg, "Did you have any time to read the PDA?") 
or that provide patients with a built-in reason for not 
reading the PDA, (eg, "I know you’ve been busy, but did 
you manage to read the PDA?"). Since reading the PDA 
does not necessarily mean understanding it, similar care 
must be taken in eliciting patients’ questions. Doctors 
should resist the habit of using ‘any,’ and instead formu-
late ‘yes’-preferring questions, for example, "Do you 
have some questions?" or "Is there something you don't 
understand?". However, this is only the beginning of the 
conversation. The reliable assessment of patient knowl-
edge requires going beyond yes/no questions to apply 
the ‘teach-back’ method, by asking patients to reformu-
late the PDA content.3
The doctors' initial PDA-related questions act as 
presequences, allowing them to approach treatment 
deliberation without explicitly mentioning ‘insulin’ or 
‘decision’. This may be useful, given the patients' fears,37 
Figure 1 Initial patient decision aid (PDA) talk and decision-making trajectory.
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misperceptions38 and resistance39 linked to insulin. Yet 
patients may still regard questions about the PDA as pres-
sure to discuss or accept the recommended treatment. 
In extracts 4 and 5, the patients respond by initiating 
new topics (needle fear and refusal of insulin) rather 
abruptly, although topic shift is usually collaborative and 
prolonged.40 This 'minimal response-topic shift’,41 along 
with paralinguistic features such as laughter, repetition 
and interjections, may indicate that patients find the 
conversation difficult.
The interactions are largely physician-centred and 
doctors’ questions are mostly closed-ended questions, 
which limit patients’ opportunities to participate. The 
doctors also seem to prioritise their own agendas over 
patient cues and contributions, continuing to refer to 
the PDA after patients disclose fears (extract 4) or state 
their preference against insulin (extracts 1 and 5). This 
may be related to the Observer’s Paradox, that is, the 
doctors’ awareness of the research focus, or because 
they want to ensure patients are informed before 
engaging in further discussion. However, being more 
patient-centred would involve following the patient's 
lead, for example, addressing fears immediately or 
acknowledging patients' preferences, and then asking 
if they want to continue discussing treatment options. 
Awareness of interactional cues, for example, that 
minimal responses and silence (extract 5) can indicate 
resistance,14 42 and that laughter (extracts 1, 2 and 4) 
can accompany talk on ‘delicate’ matters30 31 or disaf-
filiation,43 can also help doctors be more responsive. 
Moreover, even though insulin is the medically recom-
mended option, doctors can choose more neutral 
vocabulary to describe the PDA and to elicit patients’ 
views on treatment. Presenting treatment options, 
instead of limiting patients to acceptance or refusal of 
insulin20 can reduce the interactional and social burden 
imposed on patients by having to disagree with the 
doctor if they prefer not to start insulin.
The complex and chronic nature of type 2 diabetes, 
along with relatively low success in achieving glycaemic 
control,44 45 makes it necessary to improve treatment deci-
sion-making practices. Several PDAs have been developed 
and tested among patients with type 2 diabetes, including 
to empower patients in goal-setting46 and to support 
treatment decisions on statins47 and antihyperglycae-
mics.48 While enhanced decision-making47 and patient 
involvement48 are reported for the treatment PDAs, the 
goal-setting PDA had little effect on patient empow-
erment and was not fully used by many participants.46 
Referring to the latter study, Hargraves and Montori49 
recommend examining the doctor–patient consultation 
because PDAs ‘function or fail to function in this envi-
ronment’. However, the randomised trials mentioned 
rely largely on patient self-report measures, with only one 
coding doctors’ interaction using the observing patient 
involvement in decision making (OPTION) scale;48 there 
is little information about what occurred in the consulta-
tions, and how this may relate to the reported outcomes.
Through the microanalysis of interaction in several 
single cases, we have exemplified the intricacies of 
implementing a PDA on insulin for treating type 2 
diabetes in Malaysia, providing insights which may be 
useful in other contexts. This approach, however, espe-
cially in view of the sample size, does not make it possible 
to identify general patterns of PDA use. Nevertheless, 
our dataset has enabled us to describe some practices 
of doctors and patients in using a PDA in consultations 
in which the talk throws light on salient patient factors, 
including preference for complementary medicine, 
language barriers and varying perspectives on insulin. 
Future studies involving a larger collection of consulta-
tions, including by other HCPs and in other languages, 
and looking at PDA use through the entire consultation, 
could build on our findings for a broader perspective 
on PDA use in the Malaysian context.
Although our focus is on interaction, we are mindful 
that our findings may be limited by other possible influ-
encing factors, including doctors’ paternalism and 
communication skills, PDA design and delivery, and 
systemic or individual barriers to SDM. First, the inter-
actions may have been affected by differences between 
healthcare settings, particularly the time available for 
consultations and continuity of care, both of which are 
barriers/facilitators of SDM.50 51 Four of the patients 
(A3, A4 in the private clinic and C11, C12 in the public 
hospital) had seen the same doctor for their previous 
consultations, when they were given the PDA. This 
could explain the doctors’ cursory enquiries, as patient 
knowledge and concerns could have been discussed 
previously.
Moreover, as most consultations were in public 
settings, limited consultation time may have constrained 
the interaction of both doctors and patients. The varying 
time that patients had to read the PDA must also be 
noted, although the data showed that more time does 
not ensure that patients will read the PDA. Finally, the 
generally low level of education among the patients (see 
online supplementary appendix A) may be a factor in 
their lack of participation, as suggested by research on 
SDM barriers.50 51
CONCLUSION
Our analysis shows how doctor-centred practices 
impede the effective implementation of the PDA in 
initial sequences of talk, in that the doctors’ PDA-fo-
cused enquiries can overshadow patient contributions 
while also failing to ascertain patients’ knowledge. 
While the PDA aimed to support patient-centred 
decision-making, patients’ knowledge, concerns and 
preference are not sufficiently explored by the doctors, 
which may be attributed to many factors including the 
influence of habits from ordinary conversation. Effec-
tive interaction should therefore be emphasised both 
in training clinicians to use PDAs and in designing 
the content and delivery of PDAs. Further studies 
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on PDA use in different clinical contexts can inform 
these efforts by identifying patterns of interaction and 
effective practices in implementing PDAs, from when 
they are given to patients up to the conclusion of deci-
sion-making.
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